Doximar 200 mg (1 Strip =10 Pieces )
Original price was: 80.00৳ .76.00৳ Current price is: 76.00৳ .
Indications
Doximar is used to treat in following indications:
- Bronchial asthma,
- Bronchospasm,
- Chronic obstructive pulmonary disease (COPD),
- Pulmonary disease with spastic bronchial component.
Pharmacology
Dosage & Administration
Elderly: 200 mg tablet two or three times daily.
Adults: 400 mg tablet two or three times daily or as prescribed by the physician.
Children:
- >12 years of age: 10 ml syrup or 200 mg tablet two or three times daily.
- 6-12 years of age: 6-9 mg/kg body weight two times daily, i.e. if body weight is 10 kg, 3 ml (60 mg) two times daily or as prescribed by the physician.
If required daily dose of Doxophylline is 400 mg then Doxophylline SR tablet to be taken once daily or as prescribed by the physician
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Pregnancy and Lactation: Animal tests have shown that the active ingredient of Doxophylline does not interfere with pre and postnatal growth. However, as there is not sufficient clinical evidence about the effects of the drug during pregnancy, use of the drug during pregnancy should be evaluated carefully case by case on the basis of the risk-benefit ratio. The drug is contraindicated during lactation.
Effects on ability to drive and use machines: The product does not affect the patient’s alertness and therefore does not interfere with his/her ability to drive and use machines.
Precautions & Warnings
Numerous factors may reduce the hepatic clearance of xanthine derivatives with increased plasma levels of the drug. These factors include age, congestive cardiac decompensation, chronic obstructive pulmonary disease, severe liver disease, concomitant infections, and the concurrent administration of several drugs such as: erythromycin, TAO, lincomycin, clindamycin, allopurinol, cimetidine, influenza vaccine and propanolol. In these cases, it may be necessary to reduce the dosage of the drug. In case of factors that may influence the clearance of xanthine derivatives, monitoring of the concentration of the blood levels of the drug is recommended for the control of the therapeutic range.
Caution should be taken in administering the product to patients with cardiac disease, hypertension, in the elderly, in patients with severe hypoxemia, hyperthyroidism, chronic corpulmonale, congestive heart failure, liver disease, peptic ulcer and in those with renal impairment. In particular, it is to be used with caution in patients with congestive heart failure, since the clearance of the drug is considerably slower in these patients in which high blood levels may persist for long periods even after discontinuation of the treatment. There is no risk of addiction or any other form of dependence.
